Back to Search
Start Over
Evaluation of a hapten conjugate vaccine against the "zombie drug" xylazine.
- Source :
-
Chemical Communications . 5/2/2024, Vol. 60 Issue 35, p4711-4714. 4p. - Publication Year :
- 2024
-
Abstract
- Xylazine has emerged as a primary adulterant in fentanyl, exacerbating the complexity of the opioid crisis. Yet, there is no approved drug that can reverse xylazine's pathophysiology. As a prelude to monoclonal antibodies being assessed as a viable therapeutic, a vaccine inquiry was conducted evaluating the immune response in reversing xylazine induced behavior effects. [ABSTRACT FROM AUTHOR]
- Subjects :
- *XYLAZINE
*MONOCLONAL antibodies
*AZINES
*OPIOID epidemic
*VACCINES
*DRUGS
Subjects
Details
- Language :
- English
- ISSN :
- 13597345
- Volume :
- 60
- Issue :
- 35
- Database :
- Academic Search Index
- Journal :
- Chemical Communications
- Publication Type :
- Academic Journal
- Accession number :
- 176847668
- Full Text :
- https://doi.org/10.1039/d4cc00883a